We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Evofem Biosciences Inc (EVFM) USD0.0001

Sell:$0.0241 Buy:$0.0241 Change: $0.0019 (7.31%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$0.0241
Buy:$0.0241
Change: $0.0019 (7.31%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$0.0241
Buy:$0.0241
Change: $0.0019 (7.31%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health. Its commercial product, Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel (Phexxi), is a hormone-free and woman-controlled prescription contraceptive drug product available in the United States. Its lead clinical program is evaluating EVO100 for the prevention of urogenital chlamydia and gonorrhea in women. Its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), EVO200 vaginal gel, uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Contact details

Address:
12400 High Bluff Drive, Suite 600
SAN DIEGO
92130
United States
Telephone:
+1 (858) 5501900
Website:
https://www.evofem.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EVFM
ISIN:
US30048L3024
Market cap:
$278,990
Shares in issue:
10.73 million
Sector:
Pharmaceuticals
Exchange:
Off Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Saundra Pelletier
    President, Chief Executive Officer
  • Ivy Zhang
    Chief Financial Officer, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.